Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Marco ValgimigliPieter C SmitsEnrico FrigoliDario BongiovanniJan TijssenThomas HovasseAl MafragiWillem Theodoor RuifrokDimitar KarageorgievAdel AminianStefano GarducciBela MerkelyHelen RoutledgeKenji AndoJosè Francisco Diaz FernandezThomas CuissetFazila Tun Nesa MalikMajdi HalabiLoic BelleJehangir DinFarzin BeyguiAtul AbhyankarKrzysztof ReczuchGiovanni PedrazziniDik HegPascal Vranckxnull nullPublished in: European heart journal (2022)
This trial is registered with ClinicalTrials.gov, number NCT03023020, and is closed to new participants, with follow-up completed.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- phase iii
- study protocol
- st elevation myocardial infarction
- coronary artery disease
- phase ii
- atrial fibrillation
- coronary artery bypass grafting
- clinical trial
- open label
- randomized controlled trial
- heart failure
- double blind
- left ventricular